Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;25(2):218-228.
doi: 10.1002/epd2.20019. Epub 2023 May 8.

What are the predominant predictors of seizure relapse following discontinuation of anti-seizure medication in epileptic children?

Seda Kanmaz  1 , Dilara Ece Toprak  1 , Cemile Busra Olculu  1 , Ipek Dokurel  1 , Erdem Simsek  1 , Hepsen Mine Serin  1 , Sanem Yılmaz  1 , Gul Aktan  1 , Sarenur Gokben  1 , Hasan Tekgul  1
Affiliations

What are the predominant predictors of seizure relapse following discontinuation of anti-seizure medication in epileptic children?

Seda Kanmaz et al. Epileptic Disord. 2023 Apr.

Abstract

Objective: The aim of the study was to identify the predominant predictors of seizure relapse following discontinuation of ASM in epileptic children.

Methods: The study cohort consisted of 403 epileptic children who had a withdrawal process of ASM (monotherapy: 344; dual therapy or polytherapy: 59) after at least a 2-year seizure-free period. Patients were categorized if they had a well-defined epileptic syndrome. Epileptic children with ongoing ketogenic diet, vagal nerve stimulation, or surgery were excluded from the cohort due to the additional withdrawal process related to other therapy modalities.

Results: The cohort's seizure relapse rate was 12.7% (51/403). The highest rates of seizure relapse were defined for genetic etiology at 25% and structural etiology at 14.9%. An epilepsy syndrome was defined in 183 of 403 children (45.4%). There was no difference in the seizure relapse rate between the subgroups of well-defined epileptic syndromes; 13.8% for self-limited focal epileptic syndromes, 11.7% for developmental and epileptic encephalopathies, and 7.1% for generalized epileptic syndromes. Five predictors were defined as the most powerful predictors of seizure relapse in univariate analysis: age at epilepsy diagnosis >2 years (hazard ratio [HR]: 1.480; 95% confidence interval [CI]: 1.134-1.933), defined etiology (HR: 1.304; 95% CI: 1.003-1.696), focal seizure (HR: 1.499; 95% CI: 1.209-1.859), ≤3 months duration of the withdrawal process (HR: 1.654; 95% CI: 1.322-2.070), and a history of neonatal encephalopathy with or without seizures (HR: 3.140; 95% CI: 2.393-4.122). In multivariate analysis, the main predictor of seizure relapse was a history of neonatal encephalopathy with or without seizures (HR: 2.823; 95% CI: 2.067-3.854).

Significance: The duration of seizure freedom before discontinuation of ASM was not a predominant risk factor for seizure relapse: 2-3 years versus >3 years. The predictive values of five predictors of seizure relapse rate should be evaluated for patients with different epilepsy subgroups.

Keywords: ASM withdrawal; anti-seizure medication; childhood; epilepsy; predictor.

PubMed Disclaimer

References

REFERENCES

    1. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314-9.
    1. Hixson JD. Stopping antiepileptic drugs: when and why? Curr Treat Options Neurol. 2010;12(5):434-42.
    1. Lossius MI, Alfstad K, Aaberg KM, Nakken KO. Discontinuation of antiepileptic drugs in seizure-free patients - when and how? Tidsskr Nor Laegeforen. 2017;137(6):451-4.
    1. Specchio LM, Beghi E. Should antiepileptic drugs be withdrawn in seizure-free patients? CNS Drugs. 2004;18(4):201-12.
    1. Shinnar S, Berg AT, Moshé SL, Kang H, O'Dell C, Alemany M, et al. Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol. 1994;35(5):534-45.

Substances